Virtus ETF Advisers LLC - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 133 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$47,000
-69.9%
65,149
-5.6%
0.02%
-64.4%
Q4 2021$156,000
-7.1%
69,015
+18.5%
0.06%
-20.3%
Q3 2021$168,000
-27.6%
58,243
-5.0%
0.07%
-22.1%
Q2 2021$232,000
-27.5%
61,284
-35.1%
0.10%
-29.6%
Q1 2021$320,000
+23.1%
94,432
+1.8%
0.14%
+25.0%
Q4 2020$260,000
+276.8%
92,771
+236.8%
0.11%
+200.0%
Q3 2020$69,000
-83.8%
27,546
-12.0%
0.04%
-82.1%
Q2 2020$425,000
-0.5%
31,293
-44.4%
0.20%
+14.2%
Q1 2020$427,000
+4.9%
56,270
-12.7%
0.18%
+162.7%
Q4 2019$407,000
+68.2%
64,476
+4.6%
0.07%
+36.7%
Q3 2019$242,000
-23.2%
61,630
-5.3%
0.05%
-25.8%
Q2 2019$315,000
+15.0%
65,063
+94.1%
0.07%
-88.7%
Q1 2019$274,000
+29.9%
33,514
-12.2%
0.58%
+1519.4%
Q4 2018$211,000
-43.1%
38,183
-9.2%
0.04%
-5.3%
Q3 2018$371,000
-48.7%
42,037
-41.9%
0.04%
-94.1%
Q2 2018$723,000
+50.3%
72,408
+43.5%
0.64%
+53.2%
Q1 2018$481,000
+37.8%
50,462
+115.1%
0.42%
-4.8%
Q4 2017$349,000
-23.0%
23,459
+1.9%
0.44%
+618.0%
Q3 2017$453,000
+50.5%
23,019
+10.1%
0.06%
+35.6%
Q2 2017$301,000
+12.3%
20,913
-29.3%
0.04%
-65.4%
Q3 2016$268,000
+21.3%
29,5900.0%0.13%
-20.7%
Q2 2016$221,000
+14.5%
29,590
+38.1%
0.16%
-38.3%
Q1 2016$193,00021,4300.27%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$3,340,0005.66%
Orchard Capital Management, LLC 1,762,731$1,265,0000.36%
Ikarian Capital, LLC 1,200,000$860,0000.11%
Ikarian Capital, LLC 800,000$575,0000.08%
XTX Topco Ltd 102,392$74,0000.03%
Nantahala Capital Management 965,800$693,0000.03%
Worth Venture Partners, LLC 63,500$46,0000.02%
Ardent Capital Management, Inc. 43,429$31,0000.02%
Virtus ETF Advisers LLC 65,149$47,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 513,292$368,0000.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders